The Clinical Trial Imaging Market Report 2023-2033: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Factors Such As Increasing Demand for More Precise and Personalized Treatments and Growing Number of Clinical Trials Are Driving the Market Growth
Clinical trial imaging has the potential to personalize treatments by detecting patients who have specific genetic or disease subtype characteristics that would benefit from a specific drug or treatment. By doing so, the effectiveness of treatments can be enhanced and the possibility of harmful side effects can be reduced. With the increasing demand for novel and enhanced drugs and therapies, the number of clinical trials being conducted worldwide is on the rise. Clinical trial imaging plays a crucial role in these trials by allowing researchers to visualize and quantify the impact of experimental drugs and therapies on the body. Advanced medical imaging techniques like MRI, CT scans, and PET scans offer intricate images of organs, tissues, and cells, enabling identification and monitoring of disease progression, as well as evaluation of the safety and effectiveness of new treatments.
Shortage of Skilled Professional
A major limitation for the clinical trial imaging market is the scarcity of proficient experts. The proficient execution of clinical trial imaging demands skilled professionals such as radiologists, imaging technicians, and data analysts who are trained in the handling of medical imaging technology and possess expertise in data analysis and interpretation. Unfortunately, there is a lack of skilled professionals in the medical imaging field, making it difficult for companies to recruit and retain them. This shortage is more noticeable in emerging markets and specialized areas of imaging, such as nuclear medicine and molecular imaging.
What Questions Should You Ask before Buying a Market Research Report?
• How is the clinical trial imaging market evolving?
• What is driving and restraining the clinical trial imaging market?
• How will each clinical trial imaging submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trial imaging submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trial imaging markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2020 and 2033? What are the implications of clinical trial imaging projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trial imaging market?
• Where is the clinical trial imaging market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the clinical trial imaging market today, and over the next 10 years:
• Our 272-page report provides 115 tables and 162 charts/graphs exclusively to you.
• The report highlights key lucrative areas in the industry so you can target them – NOW.
• It contains in-depth analysis of global, regional and national sales and growth.
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the clinical trial imaging market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2033 and other analyses reveal commercial prospects
• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares.
• You will find original analyses, with business outlooks and developments.
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trial imaging prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Segments Covered in the Report
Software and Services
• Software
• Services
Modality
• Computed Tomography
• Magnetic Resonance Imaging
• Ultrasound
• Positron Emission Tomography
• X-ray
• Echocardiography
Therapeutic Area
• Oncology
• Infectious Diseases
• Neurology
• CVS
• Endocrinology
• Immunological Disorder
End-users
• Pharmaceutical Companies
• Biotechnology Companies
• Medical Device Manufacturer
• Contract Research Organisations
• Academic and Government Research Institutes
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:
North America
• U.S.
• Canada
Europe
• Germany
• Spain
• United Kingdom
• France
• Russia
• Italy
• Rest of Europe
Asia Pacific
• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific
Latin America
• Brazil
• Mexico
• Rest of Latin America
MEA
• GCC Countries
• South Africa
• Rest of MEA
Need industry data? Please contact us today.
The report also includes profiles and for some of the leading companies in the Clinical Trial Imaging Market, 2023 to 2033, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth
• BioTelemetry, a Philips Company
• Calyx
• Clario
• eClinical Solutions LLC
• ICON plc
• IXICO plc
• Medical Metrics, Inc.
• Medpace
• Medrio, Inc.
• Novitas Life Sciences
• Parexel International Corporation
• Perspectum
• Radiant Sage LLC
• Resonance Health Ltd
• Signant Health
Overall world revenue for clinical trial imaging market, 2023 to 2033 in terms of value the market will surpass US$1,370.7 million in 2022, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the clinical trial imaging market, 2023 to 2033 report help you?
In summary, our 270+ page report provides you with the following knowledge:
• Revenue forecasts to 2033 for clinical trial imaging market, 2023 to 2033 Market, with forecasts for software and services, modality, therapeutics, end users and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for four regional and 20 key national markets – See forecasts for the clinical trial imaging Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 15 of the major companies involved in the clinical trial imaging Market, 2023 to 2033.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else
With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the clinical trial imaging market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.
To access the data contained in this document please email contactus@visiongain.com
Buy our report today Clinical Trial Imaging Market Report 2023-2033: Forecasts by Software and Services (Software, Services), by Modality (Computed Tomography, Magnetic Resonance Imaging, Ultrasound, Positron Emission Tomography, X-ray, Echocardiography), by Therapeutic Area (Oncology, Infectious Diseases, Neurology, CVS, Endocrinology, Immunological Disorder), by End-users (Pharmaceutical Companies, Biotechnology Companies, Medical Device Manufacturer, Contract Research Organisations, Academic and Government Research Institutes) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Clinical Trial Imaging Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report
1.6 Who is This Report for?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.7.3.1 Primary Research
1.7.3.2 Secondary Research
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Visiongain Reports
1.10 About Visiongain
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.2.1 Market Driving Factors
3.2.1.1 Rising Number of Clinical Trials Coupled with Growing R&D Investments
3.2.1.2 Increasing demand for more precise and personalized treatments and diagnosis
3.2.1.3 Technological advancements in imaging modalities
3.2.2 Market Restraining Factors
3.2.2.1 Shortage and high costs of skilled professional
3.2.2.2 High cost of imaging equipment and services
3.2.2.3 Regulatory Challenges
3.2.3 Market Opportunities
3.2.3.1 Outsourcing of imaging services
3.2.3.2 Growing prevalence of chronic diseases
3.2.3.3 Increasing adoption of artificial intelligence (AI) and machine learning (ML) technologies
3.3 COVID-19 Impact Analysis
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Competitive Rivalry
3.4.4 Threat from Substitutes
3.4.5 Threat of New Entrants
3.5 PEST Analysis
4 Clinical Trial Imaging Market Analysis by Software and Services
4.1 Key Findings
4.2 Software and Services Segment: Market Attractiveness Index
4.3 Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
4.4 Services
4.4.1 Market Size by Region, 2023-2033 (US$ Million)
4.4.2 Market Share by Region, 2023 & 2033 (%)
4.4.3 Services, 2023-2033 (US$ Million)
4.5 Software
4.5.1 Market Size by Region, 2023-2033 (US$ Million)
4.5.2 Market Share by Region, 2023 & 2033 (%)
5 Clinical Trial Imaging Market Analysis by Modality
5.1 Key Findings
5.2 Modality Segment: Market Attractiveness Index
5.3 Clinical Trial Imaging Market Size Estimation and Forecast by Modality
5.4 Computed Tomography
5.4.1 Market Size by Region, 2023-2033 (US$ Million)
5.4.2 Market Share by Region, 2023 & 2033 (%)
5.5 Magnetic Resonance Imaging
5.5.1 Market Size by Region, 2023-2033 (US$ Million)
5.5.2 Market Share by Region, 2023 & 2033 (%)
5.6 Ultrasound
5.6.1 Market Size by Region, 2023-2033 (US$ Million)
5.6.2 Market Share by Region, 2023 & 2033 (%)
5.7 Positron Emission Tomography
5.7.1 Market Size by Region, 2023-2033 (US$ Million)
5.7.2 Market Share by Region, 2023 & 2033 (%)
5.8 X-ray
5.8.1 Market Size by Region, 2023-2033 (US$ Million)
5.8.2 Market Share by Region, 2023 & 2033 (%)
5.9 Echocardiography
5.9.1 Market Size by Region, 2023-2033 (US$ Million)
5.9.2 Market Share by Region, 2023 & 2033 (%)
6 Clinical Trial Imaging Market Analysis by Therapeutic Area
6.1 Key Findings
6.2 Therapeutic Area Segment: Market Attractiveness Index
6.3 Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
6.4 Oncology
6.4.1 Market Size by Region, 2023-2033 (US$ Million)
6.4.2 Market Share by Region, 2023 & 2033 (%)
6.5 Infectious diseases
6.5.1 Market Size by Region, 2023-2033 (US$ Million)
6.5.2 Market Share by Region, 2023 & 2033 (%)
6.6 Neurology
6.6.1 Market Size by Region, 2023-2033 (US$ Million)
6.6.2 Market Share by Region, 2023 & 2033 (%)
6.7 CVS
6.7.1 Market Size by Region, 2023-2033 (US$ Million)
6.7.2 Market Share by Region, 2023 & 2033 (%)
6.8 Endocrinology
6.8.1 Market Size by Region, 2023-2033 (US$ Million)
6.8.2 Market Share by Region, 2023 & 2033 (%)
6.9 Immunological Disorder
6.9.1 Market Size by Region, 2023-2033 (US$ Million)
6.9.2 Market Share by Region, 2023 & 2033 (%)
7 Clinical Trial Imaging Market Analysis by End Users
7.1 Key Findings
7.2 End Users Segment: Market Attractiveness Index
7.3 Clinical Trial Imaging Market Size Estimation and Forecast by End Users
7.4 Pharmaceutical Companies
7.4.1 Market Size by Region, 2023-2033 (US$ Million)
7.4.2 Market Share by Region, 2023 & 2033 (%)
7.5 Biotechnology Companies
7.5.1 Market Size by Region, 2023-2033 (US$ Million)
7.5.2 Market Share by Region, 2023 & 2033 (%)
7.6 Medical Device Manufacturer
7.6.1 Market Size by Region, 2023-2033 (US$ Million)
7.6.2 Market Share by Region, 2023 & 2033 (%)
7.7 Contract Research Organizations
7.7.1 Market Size by Region, 2023-2033 (US$ Million)
7.7.2 Market Share by Region, 2023 & 2033 (%)
7.8 Academic and Government Research Institutes
7.8.1 Market Size by Region, 2023-2033 (US$ Million)
7.8.2 Market Share by Region, 2023 & 2033 (%)
8 Clinical Trial Imaging Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Clinical Trial Imaging Market Analysis
9.1 Key Findings
9.2 North America Clinical Trial Imaging Market Attractiveness Index
9.3 North America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
9.4 North America Clinical Trial Imaging Market Size Estimation and Forecast by Country
9.5 North America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
9.6 North America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
9.7 North America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
9.8 North America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
9.9 U.S. Clinical Trial Imaging Market Analysis
9.10 Canada Clinical Trial Imaging Market Analysis
10 Europe Clinical Trial Imaging Market Analysis
10.1 Key Findings
10.2 Europe Clinical Trial Imaging Market Attractiveness Index
10.3 Europe Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
10.4 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Country
10.5 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
10.6 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Modality
10.7 Europe Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
10.8 Europe Clinical Trial Imaging Market Size Estimation and Forecast by End Users
10.9 Germany Clinical Trial Imaging Market Analysis
10.10 France Clinical Trial Imaging Market Analysis
10.11 U.K. Clinical Trial Imaging Market Analysis
10.12 Italy Clinical Trial Imaging Market Analysis
10.13 Spain Clinical Trial Imaging Market Analysis
10.14 Russia Clinical Trial Imaging Market Analysis
10.15 Rest of Europe Clinical Trial Imaging Market Analysis
11 Asia Pacific Clinical Trial Imaging Market Analysis
11.1 Key Findings
11.2 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
11.3 Asia Pacific Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
11.4 Asia Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Country
11.5 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
11.6 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Modality
11.7 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
11.8 Asia-Pacific Clinical Trial Imaging Market Size Estimation and Forecast by End Users
11.9 China Clinical Trial Imaging Market Analysis
11.10 Japan Clinical Trial Imaging Market Analysis
11.11 India Clinical Trial Imaging Market Analysis
11.12 Australia Clinical Trial Imaging Market Analysis
11.13 South Korea clinical trial imaging Market Analysis
11.14 Rest of Asia Pacific Clinical Trial Imaging Market Analysis
12 Latin America Clinical Trial Imaging Market Analysis
12.1 Key Findings
12.2 Latin America Clinical Trial Imaging Market Attractiveness Index
12.3 Latin America Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
12.4 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Country
12.5 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
12.6 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Modality
12.7 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
12.8 Latin America Clinical Trial Imaging Market Size Estimation and Forecast by End Users
12.9 Brazil Clinical Trial Imaging Market Analysis
12.10 Mexico Clinical Trial Imaging Market Analysis
12.11 Rest of Latin America Clinical Trial Imaging Market Analysis
13 MEA Clinical Trial Imaging Market Analysis
13.1 Key Findings
13.2 MEA Clinical Trial Imaging Market Attractiveness Index
13.3 MEA Clinical Trial Imaging Market by Country, 2023, 2028 & 2033 (US$ Million)
13.4 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Country
13.5 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Software and Services
13.6 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Modality
13.7 MEA Clinical Trial Imaging Market Size Estimation and Forecast by Therapeutic Area
13.8 MEA Clinical Trial Imaging Market Size Estimation and Forecast by End Users
13.9 GCC Clinical Trial Imaging Market Analysis
13.10 South Africa Clinical Trial Imaging Market Analysis
13.11 Rest of MEA Clinical Trial Imaging Market Analysis
14 Company Profiles
14.1 Competitive Landscape, 2022
14.2 Strategic Outlook
14.3 ICON plc
14.3.1 Company Snapshot
14.3.2 Company Overview
14.3.3 Financial Analysis
14.3.3.1 Revenue, 2018-2022
14.3.3.2 Regional Market Shares, 2022
14.3.4 Product Benchmarking
14.3.5 Strategic Outlook
14.4 BioTelemetry, a Philips Company
14.4.1 Company Snapshot
14.4.2 Company Overview
14.4.3 Financial Analysis
14.4.3.1 Revenue, 2018-2022
14.4.3.2 Regional Market Shares, 2021
14.4.3.3 R&D Expense, 2017-2021
14.4.4 Product Benchmarking
14.4.5 Strategic Outlook
14.5 Clario
14.5.1 Company Snapshot
14.5.2 Company Overview
14.5.3 Product Benchmarking
14.5.4 Strategic Outlook
14.6 Navitas Life Sciences
14.6.1 Company Snapshot
14.6.2 Company Overview
14.6.3 Product Benchmarking
14.6.4 Strategic Outlook
14.7 Resonance Health Ltd
14.7.1 Company Snapshot
14.7.2 Company Overview
14.7.3 Financial Analysis
14.7.3.1 Revenue, 2018-2021
14.7.3.2 Regional Market Shares, 2021
14.7.4 Product Benchmarking
14.8 Parexel International Corporation
14.8.1 Company Snapshot
14.8.2 Company Overview
14.8.3 Product Benchmarking
14.8.4 Strategic Outlook
14.9 Medrio, Inc.
14.9.1 Company Snapshot
14.9.2 Company Overview
14.9.3 Product Benchmarking
14.9.4 Strategic Outlook
14.10 Signant Health
14.10.1 Company Snapshot
14.10.2 Company Overview
14.10.3 Product Benchmarking
14.10.4 Strategic Outlook
14.11 Perspectum
14.11.1 Company Snapshot
14.11.2 Company Overview
14.11.3 Product Benchmarking
14.11.4 Strategic Outlook
14.12 Medical Metrics, Inc.
14.12.1 Company Snapshot
14.12.2 Company Overview
14.12.3 Product Benchmarking
14.13 Calyx
14.13.1 Company Snapshot
14.13.2 Company Overview
14.13.3 Product Benchmarking
14.13.4 Strategic Outlook
14.14 Radiant Sage LLC
14.14.1 Company Snapshot
14.14.2 Company Overview
14.14.3 Product Benchmarking
14.15 Medpace
14.15.1 Company Snapshot
14.15.2 Company Overview
14.15.3 Financial Analysis
14.15.3.1 Revenue, 2018-2022
14.15.3.2 Regional Market Shares, 2021
14.15.4 Product Benchmarking
14.16 IXICO plc
14.16.1 Company Snapshot
14.16.2 Company Overview
14.16.3 Financial Analysis
14.16.3.1 Revenue, 2018-2022
14.16.3.2 Regional Market Shares, 2021
14.16.3.3 R&D Expense, 2017-2021
14.16.4 Product Benchmarking
14.16.5 Strategic Outlook
15 Conclusion and Recommendations
15.1 Concluding Remarks from Visiongain
15.2 Recommendations for Market Players
List of Tables
Table 1 Clinical Trial Imaging Market Snapshot, 2023 & 2033 (US$ million, CAGR %)
Table 1 Total Clinical Trials by Phase of Development
Table 2 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
Table 3 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
Table 4 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 5 Global Clinical Trial Imaging Market Forecast by Region 2023-2033 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
Table 6 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 7 Services Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 8 Global Clinical Trial Imaging Market Forecast by Services, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 9 Software Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 10 Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 11 Computed Tomography Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 12 Magnetic Resonance Imaging Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 13 Ultrasound Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 14 Positron Emission Tomography Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR %)
Table 15 X-ray Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 16 Echocardiography Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 17 Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Mn,
AGR%, CAGR %)
Table 18 Oncology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 19 Infectious Diseases Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 20 Neurology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 21 CVS Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 22 Endocrinology Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 23 Immunology Disorder Segment Market Forecast by Region, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 24 Clinical Trial Imaging Market Forecast by End User, 2023-2033 (US$ Mn, AGR%, CAGR%)
Table 25 Pharmaceutical Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 26 Biotechnology Companies Segment Market Forecast by Region, 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 27 Medical Device Manufacturer Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 28 Contract Research Organizations Segment Market Forecast by Region, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 29 Academic and Government Research Institutes Segment Market Forecast by Region,
2023-2033, (US$ Million, AGR%, CAGR%)
Table 30 Global Clinical Trial Imaging Market Forecast by Region 2023-2033, (US$ Mn, AGR%, CAGR%)
Table 31 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 32 Global Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 33 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
Table 34 North America Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR %)
Table 35 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 36 U.S. Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 37 Canada Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR %)
Table 38 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million,
AGR%, CAGR %)
Table 39 Europe Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 40 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 41 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 42 Europe Clinical Trial Imaging Market Forecast by Modality 2023-2033
(US$ Million, AGR%, CAGR%)
Table 43 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 44 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 45 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 46 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 47 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 48 Russia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 49 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 50 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 51 Asia Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 52 Asia Pacific Clinical Trial Imaging Market Forecast by Modality 2023-2033(US$ Million,
AGR%, CAGR%)
Table 53 Asia Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 54 Asia Pacific Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 55 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 56 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 57 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 58 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 59 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 60 Asia-Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 61 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 62 Latin America Clinical Trial Imaging Market Forecast by Software & Serices, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 63 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033
(US$ Million, AGR%, CAGR%)
Table 64 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-
2033 (US$ Million, AGR%, CAGR%)
Table 65 Latin America Clinical Trial Imaging Market Forecast by End Users 2023-2033 (US$ Million, AGR%, CAGR%)
Table 66 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 67 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 68 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 69 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 70 MEA Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 71 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million,
AGR%, CAGR%)
Table 72 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area 2023-2033
(US$ Million, AGR%, CAGR%)
Table 73 MEA Clinical Trial Imaging Market Forecast by Modality 2023-2033 (US$ Million, AGR%, CAGR%)
Table 74 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 75 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 76 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR%, CAGR%)
Table 77 Strategic Outlook
Table 78 ICON plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 79 ICON plc: Product Benchmarking
Table 80 ICON plc: Strategic Outlook
Table 81 BioTelemetry, A Philips Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 82 BioTelemetry, A Philips Company: Product Benchmarking
Table 83 BioTelemetry, A Philips Company: Strategic Outlook
Table 84 Clario: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 85 Clario: Product Benchmarking
Table 86 Clario: Strategic Outlook
Table 87 Navitas Life Sciences: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 88 Navitas Life Sciences: Product Benchmarking
Table 89 Navitas Life Sciences: Strategic Outlook
Table 90 Resonance Health Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 91 Resonance Health Ltd: Product Benchmarking
Table 92 Parexel International Corporation: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 93 Parexel International Corporation.: Product Benchmarking
Table 94 Parexel International Corporation: Strategic Outlook
Table 95 Medrio, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 96 Medrio, Inc.: Product Benchmarking
Table 97 Medrio, Inc.: Strategic Outlook
Table 98 Signant Health: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 99 Signant Health: Product Benchmarking
Table 100 Signant Health: Strategic Outlook
Table 101 Perspectum: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 102 Perspectum: Product Benchmarking
Table 103 Perspectum: Strategic Outlook
Table 104 Medical Metrics, Inc.: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 105 Medical Metrics, Inc.: Product Benchmarking
Table 106 Calyx: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 107 Calyx: Product Benchmarking
Table 108 Calyx: Strategic Outlook
Table 109 Radiant Sage LLC: Key Details, (CEO, HQ, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 110 Radiant Sage LLC: Product Benchmarking
Table 111 Medpace: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 112 Medpace: Product Benchmarking
Table 113 IXICO plc: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 114 IXICO plc: Product Benchmarking
Table 115 IXICO plc: Strategic Outlook
List of Figures
Figure 1 Clinical Trial Imaging Market Segmentation
Figure 2 Clinical Trial Imaging Market by Software and Services: Market Attractiveness Index
Figure 3 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
Figure 4 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 5 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
Figure 6 Clinical Trial Imaging Market Attractiveness Index by Region
Figure 7 Clinical Trial Imaging Market: Market Dynamics
Figure 8 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery
Figure 9 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery
Figure 10 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery
Figure 11 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery
Figure 12 Clinical Trial Imaging Market: Porter’s Five Forces Analysis
Figure 13 Clinical Trial Imaging Market: PEST Analysis
Figure 14 Clinical Trial Imaging Market Forecast by Software And Services: Market Attractiveness Index
Figure 15 Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 16 Clinical Trial Imaging Market Share Forecast by Software and Services, 2023, 2028, 2033 (%)
Figure 17 Services Market Forecast by Region, 2023 2033 (US$ Million)
Figure 18 Services Market Share Forecast by Region, 2023 & 2033 (%)
Figure 19 Services Market Forecast by Region, 2023 2033 (US$ Million)
Figure 20 Clinical Trial Imaging Market Share Forecast by Services, 2023, 2028, 2033 (%)
Figure 21 Software Market Forecast by Region, 2023-2033 (US$ million)
Figure 22 Software Market Share Forecast by Region, 2023 & 2033 (%)
Figure 23 Clinical Trial Imaging Market Forecast by Modality: Market Attractiveness Index
Figure 24 Clinical Trial Imaging Market Forecast By Modality, 2023-2033 (US$ Million)
Figure 25 Clinical Trial Imaging Market Share Forecast by Modality, 2023, 2028, 2033 (%)
Figure 26 Computed Tomography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 27 Computed Tomography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 28 Magnetic Resonance Imaging Market Forecast by Region, 2023-2033 (US$ Million)
Figure 29 Magnetic Resonance Imaging Market Share Forecast by Region, 2023 & 2033 (%)
Figure 30 Ultrasound Market Forecast by Region, 2023-2033 (US$ Million)
Figure 31 Ultrasound Market Share Forecast by Region, 2023 & 2033 (%)
Figure 32 Positron Emission Tomography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 33 Positron Emission Tomography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 34 X-ray Market Forecast by Region, 2023-2033 (US$ Million)
Figure 35 X-ray Market Share Forecast by Region, 2023 & 2033 (%)
Figure 36 Echocardiography Market Forecast by Region, 2023-2033 (US$ Million)
Figure 37 Echocardiography Market Share Forecast by Region, 2023 & 2033 (%)
Figure 38 Clinical Trial Imaging Market Forecast by Therapeutic Area: Market Attractiveness Index
Figure 39 Clinical Trial Imaging Market Forecast By Therapeutic Area, 2023-2033 (US$ Million)
Figure 40 Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023, 2028, 2033 (%)
Figure 41 Oncology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 42 Oncology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 43 Infectious diseases Market Forecast by Region, 2023-2033 (US$ Million)
Figure 44 Infectious diseases Market Share Forecast by Region, 2023 & 2033 (%)
Figure 45 Neurology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 46 Neurology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 47 CVS Market Forecast by Region, 2023-2033 (US$ Million)
Figure 48 CVS Market Share Forecast by Region, 2023 & 2033 (%)
Figure 49 Endocrinology Market Forecast by Region, 2023-2033 (US$ Million)
Figure 50 Endocrinology Market Share Forecast by Region, 2023 & 2033 (%)
Figure 51 Immunological Disorder Market Forecast by Region, 2023-2033 (US$ Million)
Figure 52 Immunological Disorder Market Share Forecast by Region, 2023 & 2033 (%)
Figure 53 Clinical Trial Imaging Market Forecast by End Users: Market Attractiveness Index
Figure 54 Clinical Trial Imaging Market Forecast By End Users, 2023-2033 (US$ Million)
Figure 55 Clinical Trial Imaging Market Share Forecast by End Users, 2023, 2028, 2033 (%)
Figure 56 Pharmaceutical Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 57 Pharmaceutical Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 58 Biotechnology Companies Market Forecast by Region, 2023-2033 (US$ Million)
Figure 59 Biotechnology Companies Market Share Forecast by Region, 2023 & 2033 (%)
Figure 60 Medical Device Manufacturer Market Forecast by Region, 2023-2033 (US$ Million)
Figure 61 Medical Device Manufacturer Market Share Forecast by Region, 2023 & 2033 (%)
Figure 62 Contract Research Organizations Market Forecast by Region, 2023-2033 (US$ Million)
Figure 63 Contract Research Organizations Market Share Forecast by Region, 2023 & 2033 (%)
Figure 64 Academic and Government Research Institutes Market Forecast by Region, 2023-2033 (US$ Million)
Figure 65 Academic and Government Research Institutes Market Share Forecast by Region, 2023 & 2033 (%)
Figure 66 Clinical Trial Imaging Market Forecast by Region 2023 & 2033 (Revenue, CAGR%)
Figure 67 Clinical Trial Imaging Market Share Forecast by Region 2023, 2028, 2033(%)
Figure 68 Clinical Trial Imaging Market by Region, 2023-2033 (US$ Million, AGR (%), CAGR (%))
Figure 69 North America Clinical Trial Imaging Market Attractiveness Index
Figure 70 North America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 71 North America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
Figure 72 North America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 73 North America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 74 North America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 75 North America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
Figure 76 North America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 77 North America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 78 North America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 79 North America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 80 North America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 81 U.S. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 82 Canada Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 83 Europe Clinical Trial Imaging Market Attractiveness Index
Figure 84 Europe Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 85 Europe Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 86 Europe Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 87 Europe Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ Million)
Figure 88 Europe Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 89 Europe Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 90 Europe Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 91 Europe Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 92 Europe Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 93 Europe Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 94 Europe Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 95 Germany Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 96 France Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 97 U.K. Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 98 Italy Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 99 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 100 Spain Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 101 Rest of Europe Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 102 Asia Pacific Clinical Trial Imaging Market Attractiveness Index
Figure 103 Asia Pacific Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 104 Asia Pacific Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ million)
Figure 105 Asia Pacific Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 106 Asia-Pacific Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ Million)
Figure 107 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 108 Asia-Pacific Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ million)
Figure 109 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 110 Asia-Pacific Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ million)
Figure 111 Asia-Pacific Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 112 Asia-Pacific Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ million)
Figure 113 Asia-Pacific Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 114 China Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 115 Japan Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 116 India Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 117 Australia Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 118 South Korea Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 119 Rest of Asia Pacific Clinical Trial Imaging Market Forecast, 2023-2033 (US$ million, AGR %)
Figure 120 Latin America Clinical Trial Imaging Market Attractiveness Index
Figure 121 Latin America Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ million)
Figure 122 Latin America Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 123 Latin America Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 124 Latin America Clinical Trial Imaging Market Forecast by Software and Services, 2023-2033 (US$ million)
Figure 125 Latin America Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 126 Latin America Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 127 Latin America Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 128 Latin America Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 129 Latin America Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 130 Latin America Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 131 Latin America Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 132 Brazil Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 133 Mexico Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 134 Rest of Latin America Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 135 MEA Clinical Trial Imaging Market Attractiveness Index
Figure 136 MEA Clinical Trial Imaging Market by Region, 2023, 2028 & 2033 (US$ Million)
Figure 137 MEA Clinical Trial Imaging Market Forecast by Country, 2023-2033 (US$ Million)
Figure 138 MEA Clinical Trial Imaging Market Share Forecast by Country, 2023 & 2033 (%)
Figure 139 MEA Clinical Trial Imaging Market Forecast by software and services, 2023-2033 (US$ million)
Figure 140 MEA Clinical Trial Imaging Market Share Forecast by Software and Services, 2023 & 2033 (%)
Figure 141 MEA Clinical Trial Imaging Market Forecast by Modality, 2023-2033 (US$ Million)
Figure 142 MEA Clinical Trial Imaging Market Share Forecast by Modality, 2023 & 2033 (%)
Figure 143 MEA Clinical Trial Imaging Market Forecast by Therapeutic Area, 2023-2033 (US$ Million)
Figure 144 MEA Clinical Trial Imaging Market Share Forecast by Therapeutic Area, 2023 & 2033 (%)
Figure 145 MEA Clinical Trial Imaging Market Forecast by End Users, 2023-2033 (US$ Million)
Figure 146 MEA Clinical Trial Imaging Market Share Forecast by End Users, 2023 & 2033 (%)
Figure 147 GCC Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 148 South Africa Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 149 Rest of MEA Clinical Trial Imaging Market Forecast, 2023-2033 (US$ Million, AGR %)
Figure 150 Clinical Trial Imaging Market: Company Share/Ranking, 2022
Figure 151 ICON plc: Net Revenue, 2018-2022 (US$ Million, AGR%)
Figure 152 ICON plc: Regional Market Shares, 2022
Figure 153 BioTelemetry, A Philips Company: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 154 BioTelemetry, A Philips Company: Regional Market Shares, 2022
Figure 155 BioTelemetry, A Philips Company: R&D Expense, 2018-2022 (US$ Million, AGR%)
Figure 156 Resonance Health Ltd: Revenue, 2018-2021 (US$ Million, AGR%)
Figure 157 Resonance Health Ltd: Regional Market Shares, 2021
Figure 158 Medpace: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 159 Medpace: Regional Market Shares, 2022
Figure 160 IXICO plc: Revenue, 2018-2022 (US$ Million, AGR%)
Figure 161 IXICO plc: Regional Market Shares, 2022
Figure 162 IXICO plc: R&D Expense, 2018-2022 (US$ Million, AGR%)
List of Companies Profiled in the report
BioTelemetry, a Philips Company
Calyx
Clario
eClinical Solutions LLC
ICON plc
IXICO plc
Medical Metrics, Inc.
Medpace
Medrio, Inc.
Novitas Life Sciences
Parexel International Corporation
Perspectum
Radiant Sage LLC
Resonance Health Ltd
Signant Health
List of Other Companies Mentioned in the report
Alimentiv Inc.
BioTel Research
Satisfai Health, Inc.
Siemens
Syneos Health
Telix Pharmaceuticals Limited
WCG Imaging
WORLDCARE CLINICAL
List of Associations Mentioned in the Report
American Cancer Society
American College of Rheumatology
American Thyroid Association
Canada Foundation for Innovation
Centers for Disease Control and Prevention
European Medicines Agency
French National Agency for Medicines and Health Products Safety (ANSM)
French National Institute of Cancer (INCa)
International Diabetes Federation
National Clinical Research Center for Geriatric Disorders
Organization for Economic Co-operation and Development
World Health Organization
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
